Deciphering mortality risk of antidiabetic medications in well-treated heart failure patients with diabetes mellitus

dc.contributor.authorColluoglu, I. T.
dc.contributor.authorCelik, A.
dc.contributor.authorAta, N.
dc.contributor.authorUral, D.
dc.contributor.authorSahin, A.
dc.contributor.authorUlgu, M. M.
dc.contributor.authorKanik, A.
dc.date.accessioned2025-05-04T16:47:37Z
dc.date.available2025-05-04T16:47:37Z
dc.date.issued2024
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage329
dc.identifier.issn1388-9842
dc.identifier.issn1879-0844
dc.identifier.scopusqualityQ1
dc.identifier.startpage328
dc.identifier.urihttps://hdl.handle.net/20.500.12418/35688
dc.identifier.volume26
dc.identifier.wosWOS:001290635502226
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofEuropean Journal of Heart Failure
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250504
dc.titleDeciphering mortality risk of antidiabetic medications in well-treated heart failure patients with diabetes mellitus
dc.typeConference Object

Dosyalar